- Home
- APTO vs GSIW Comparison
APTO vs GSIW Comparison
Compare APTO & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APTO
- GSIW
- Stock Information
- Founded
- APTO 1986
- GSIW 2016
- Country
- APTO Canada
- GSIW Hong Kong
- Employees
- APTO N/A
- GSIW N/A
- Industry
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- GSIW
- Sector
- APTO Health Care
- GSIW
- Exchange
- APTO Nasdaq
- GSIW Nasdaq
- Market Cap
- APTO 11.5M
- GSIW 10.5M
- IPO Year
- APTO N/A
- GSIW 2023
- Fundamental
- Price
- APTO $0.18
- GSIW $0.58
- Analyst Decision
- APTO Strong Buy
- GSIW
- Analyst Count
- APTO 3
- GSIW 0
- Target Price
- APTO $4.33
- GSIW N/A
- AVG Volume (30 Days)
- APTO 1.4M
- GSIW 174.0K
- Earning Date
- APTO 11-08-2024
- GSIW 12-24-2024
- Dividend Yield
- APTO N/A
- GSIW N/A
- EPS Growth
- APTO N/A
- GSIW N/A
- EPS
- APTO N/A
- GSIW N/A
- Revenue
- APTO N/A
- GSIW $1,408,469.00
- Revenue This Year
- APTO N/A
- GSIW N/A
- Revenue Next Year
- APTO N/A
- GSIW N/A
- P/E Ratio
- APTO N/A
- GSIW N/A
- Revenue Growth
- APTO N/A
- GSIW N/A
- 52 Week Low
- APTO $0.13
- GSIW $0.53
- 52 Week High
- APTO $2.68
- GSIW $15.99
- Technical
- Relative Strength Index (RSI)
- APTO 29.73
- GSIW 36.80
- Support Level
- APTO $0.18
- GSIW $0.55
- Resistance Level
- APTO $0.22
- GSIW $0.64
- Average True Range (ATR)
- APTO 0.01
- GSIW 0.06
- MACD
- APTO 0.01
- GSIW 0.04
- Stochastic Oscillator
- APTO 22.50
- GSIW 21.83
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.